- Home
- KD vs ASND Comparison
KD vs ASND Comparison
Compare KD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KD
- ASND
- Stock Information
- Founded
- KD 2020
- ASND 2006
- Country
- KD United States
- ASND Denmark
- Employees
- KD N/A
- ASND N/A
- Industry
- KD EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- KD Technology
- ASND Health Care
- Exchange
- KD Nasdaq
- ASND Nasdaq
- Market Cap
- KD 9.6B
- ASND 9.8B
- IPO Year
- KD N/A
- ASND 2015
- Fundamental
- Price
- KD $39.73
- ASND $174.40
- Analyst Decision
- KD Strong Buy
- ASND Strong Buy
- Analyst Count
- KD 3
- ASND 16
- Target Price
- KD $43.33
- ASND $214.50
- AVG Volume (30 Days)
- KD 1.9M
- ASND 464.8K
- Earning Date
- KD 07-30-2025
- ASND 05-01-2025
- Dividend Yield
- KD N/A
- ASND N/A
- EPS Growth
- KD N/A
- ASND N/A
- EPS
- KD 1.05
- ASND N/A
- Revenue
- KD $15,057,000,000.00
- ASND $398,509,511.00
- Revenue This Year
- KD $6.38
- ASND $76.54
- Revenue Next Year
- KD $2.58
- ASND $77.42
- P/E Ratio
- KD $37.83
- ASND N/A
- Revenue Growth
- KD N/A
- ASND 12.06
- 52 Week Low
- KD $21.34
- ASND $111.09
- 52 Week High
- KD $43.61
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- KD 65.53
- ASND 63.75
- Support Level
- KD $38.14
- ASND $156.56
- Resistance Level
- KD $39.82
- ASND $163.55
- Average True Range (ATR)
- KD 0.78
- ASND 6.49
- MACD
- KD -0.23
- ASND 1.42
- Stochastic Oscillator
- KD 46.21
- ASND 82.46
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.